[ad_1] Is Omicron really ‘mild’? Or is it just ‘milder’? Keith Lynch attempts to quantify the risk Covid poses and explains the ‘mildness’ conundrum is, well, complicated. There’s a single word that keeps popping up when people talk about Omicron – “mild”. For most people, Associate Health Minister Ayesha Verrall has said, Omicron would be […]
Continue Reading
[ad_1] While they may not be hospitalized for respiratory illnesses, “we are seeing some exacerbation of other conditions in individuals who are vulnerable,” said Dr. Sandra Nelson, an infectious disease specialist at Massachusetts General Hospital and an assistant professor of medicine at Harvard Medical School. In some cases, patients were dehydrated from the effects of […]
Continue Reading
[ad_1] Neurological symptoms have been commonly reported in those suffering from post-COVID conditions – lingering symptoms experienced four or more weeks after an initial infection. But a new study by researchers at Yale University found even those who contract mild infections can sustain neurological damage. In an interview with NBC Connecticut, Dr. Akiko Iwasaki, who […]
Continue Reading
[ad_1] Dr. Akiko Iwasaki, an immunologist with the Yale School of Medicine has been researching potential long-term effects of getting COVID-19. In a recent study, Iwasaki has discovered that even people with mild symptoms can sometimes suffer long-term neurological damage. NBC Connecticut’s Dan Corcoran spoke with her about the issue. Dan: “So you’ve been doing […]
Continue Reading